A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Completed · Phase 4

Conditions studied: Acne Vulgaris

In brief

This study will evaluate the effect of dapsone gel in female subjects with skin of color (Fitzpatrick Skin Types IV, V, and VI) with acne vulgaris.

Key facts

Study ID

NCT02032407

Run by

Allergan

People needed

68

Starts

2013-12-01

Expected to finish

2014-09-01

Last updated by the study team

2015-08-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of acne vulgaris
• Medium to dark complexion (Fitzpatrick Skin Type IV, V or VI)
• Willing to avoid excessive or prolonged exposure of the face to ultraviolet light (eg, sunlight, tanning beds) throughout the study

You may not qualify if…

• Received treatment with botulinum toxin of any serotype in the face within 6 months

Where it is running

• Study site — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.